Related Experiment Videos
[Soluble lymphocyte antigens in hematological diseases]
A Yoneyama1, M Higashihara, K Nakahara
1First Department of Internal Medicine, Faculty of Medicine, University of Tokyo.
Summary
Soluble CD8 (sCD8) and soluble CD4 (sCD4) levels significantly increase in infectious mononucleosis (IM) and various hematological malignancies. These elevated markers suggest prolonged lymphocyte activation and can aid in monitoring disease status.
Area of Science:
- Immunology
- Hematology
- Virology
Background:
- Soluble CD8 (sCD8) and soluble CD4 (sCD4) are circulating forms of T-cell surface proteins.
- Elevated levels of these soluble molecules have been observed in various immune and malignant conditions.
Purpose of the Study:
- To investigate plasma levels of sCD8 and sCD4 in patients with infectious mononucleosis (IM) and hematological disorders.
- To determine the correlation between sCD8 and sCD4 levels and disease activity in these patient groups.
Main Methods:
- Quantitative analysis of plasma sCD8 and sCD4 levels using specified units (U/ml).
- Comparison of levels between patient cohorts (IM, hematological malignancies) and healthy controls.
- Longitudinal monitoring of sCD8 and sCD4 levels during convalescence from IM.
Main Results:
- Infectious mononucleosis patients exhibited markedly elevated sCD8 and significantly increased sCD4 levels, indicating robust CD8+ and CD4+ lymphocyte activation.
- Elevated sCD8 in IM is attributed to both CD8+ cell expansion and increased release per cell; increased sCD4 release from CD4+ cells was also observed.
- Elevated sCD4 and sCD8 levels were detected in non-Hodgkin lymphoma (NHL), acute lymphocytic leukemia, multiple myeloma, acute non-lymphocytic leukemia, and chronic myelogenous leukemia.
- In NHL patients, sCD4 and sCD8 levels correlated with disease status and were useful for monitoring disease activity.
Conclusions:
- Elevated sCD8 and sCD4 levels are indicative of significant lymphocyte activation in infectious mononucleosis.
- Persistent elevation of sCD8 and sCD4 post-IM suggests prolonged immune activation.
- Serum sCD4 and sCD8 levels serve as valuable biomarkers for disease status and activity monitoring in specific hematological malignancies, particularly NHL.